Primary Open-Angle Glaucoma

CHICAGO — Once-daily sepetaprost was noninferior to twice-daily timolol in reducing IOP in patients with primary open-angle glaucoma or ocular hypertension, according to a study presented at the American Academy of Ophthalmology meeting.

Social functioning and dependency were significantly worse in patients with primary open-angle glaucoma compared with patients with normal tension glaucoma, according to a study published in the Journal of Glaucoma.

Shared genetic etiology was observed between myopic refractive error and the risk for primary open-angle glaucoma, according to a study in JAMA Ophthalmology.

Black patients had a higher risk for developing advanced visual field loss after a new diagnosis of primary open-angle glaucoma, according to a study.

Once-daily fixed combination bimatoprost, timolol and brimonidine more effectively reduced peak IOP compared with a twice-daily regimen in patients with primary open-angle glaucoma, according to a study in the Journal of Glaucoma.

Tinnitus was significantly associated with pre-existing primary open-angle glaucoma, researchers reported in the Journal of Glaucoma.

Automated deep learning analysis of fundus photographs showed high diagnostic accuracy in determining primary open-angle glaucoma, with increased ability to detect glaucoma earlier than human readers.

Two-year results of a multicenter European study showed that the Preserflo microshunt, an ab externo filtration surgery device, safely reduced IOP in eyes with primary open-angle glaucoma.

The cumulative incidence of primary open-angle glaucoma after 20 years was almost 50% in patients with ocular hypertension, and the cumulative incidence of visual field loss was 25%, according to a study published in JAMA Ophthalmology.

December glaucoma news includes updates on standalone MIGS surgery as well as a video from the American Academy of Ophthalmology meeting.